AMNI.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:29):

Stats
Today's Volume	5.85M
Average Volume	24.41M
Market Cap	10.30M
EPS	SEK-0.00938 ( 2023-11-27 )
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-0.0300
ATR14	SEK0 (0.00%)

Amniotics AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Amniotics AB (publ) Financials

Annual	2023
Revenue:	SEK0
Gross Profit:	SEK-2.30M (0.00 %)
EPS:	SEK-0.0676

Q4	2023
Revenue:	SEK0
Gross Profit:	SEK-471 000 (0.00 %)
EPS:	SEK-0.00400

Q3	2023
Revenue:	SEK0
Gross Profit:	SEK-471 000 (0.00 %)
EPS:	SEK-0.120

Q2	2023
Revenue:	SEK0
Gross Profit:	SEK-502 000 (0.00 %)
EPS:	SEK-0.120

Financial Reports:

No articles found.

Amniotics AB (publ)

Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; and CutiStem for the treatment of dermatological indications. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB (publ) was incorporated in 2015 and is based in Lund, Sweden.